What is the True Solubility Advantage for Amorphous Pharmaceuticals?
Top Cited Papers
- 1 January 2000
- journal article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 17 (4), 397-404
- https://doi.org/10.1023/a:1007516718048
Abstract
Purpose. To evaluate the magnitude of the solubility advantage foramorphous pharmaceutical materials when compared to their crystallinecounterparts. Methods. The thermal properties of several drugs...Keywords
This publication has 17 references indexed in Scilit:
- Differential Molar Heat Capacities to Test Ideal Solubility EstimationsPharmaceutical Research, 1997
- Characteristics and Significance of the Amorphous State in Pharmaceutical SystemsJournal of Pharmaceutical Sciences, 1997
- Pharmaceutical Solids: A Strategic Approach to Regulatory ConsiderationsPharmaceutical Research, 1995
- Heat of Fusion Measurement of a Low Melting Polymorph of Carbamazepine That Undergoes Multiple-Phase Changes During Differential Scanning Calorimetry AnalysisJournal of Pharmaceutical Sciences, 1991
- Solid and Liquid Heat Capacities of n-Alkyl Para-aminobenzoates Near the Melting PointPharmaceutical Research, 1990
- Stability and several physical properties of amorphous and crystalline forms of indomethacin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1980
- Physico-chemical Property and Gastrointestinal Absorption of Some Solid Phases of TetracyclineYAKUGAKU ZASSHI, 1975
- Dissolution Behavior of Polymorphs of Chloramphenicol Palmitate and Mefenamic AcidJournal of Pharmaceutical Sciences, 1969
- Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitateJournal of Pharmaceutical Sciences, 1967
- Polymorphism and Drug AvailabilityJournal of Pharmaceutical Sciences, 1963